Comparison of de novo IgM and IgG anti-HLA DSAs between belatacept- and calcineurin-treated patients: An analysis of the BENEFIT and BENEFIT-EXT trial cohorts
Author:
Affiliation:
1. Terasaki Research Institute; Los Angeles CA USA
2. Immunology Biomarker Group; Bristol-Myers Squibb; Princeton NJ USA
3. Emory University School of Medicine; Pathology& Laboratory Medicine; Atlanta GA USA
Funder
Bristol-Myers Squibb
Publisher
Wiley
Subject
Pharmacology (medical),Transplantation,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14939/fullpdf
Reference29 articles.
1. Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy;Loupy;Am J Transplant,2011
2. Complement-binding anti-HLA antibodies and kidney-allograft survival;Loupy;N Engl J Med,2013
3. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant;Wiebe;Am J Transplant,2012
4. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts;Everly;Transplantation,2013
5. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure;Einecke;Am J Transplant,2009
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. IgM marks persistent IgG anti-human leukocyte antigen antibodies in highly sensitized heart transplant patients;The Journal of Heart and Lung Transplantation;2024-02
2. Cellular Immunobiology and Molecular Mechanisms in Alloimmunity—Pathways of Immunosuppression;Transplantation;2023-12-13
3. Assessment and management of allosensitization following heart transplant in adults;The Journal of Heart and Lung Transplantation;2023-04
4. Sensitization in transplantation: Assessment of Risk 2022 Working Group Meeting Report;American Journal of Transplantation;2023-01
5. Chronic CD40L blockade is required for long-term cardiac allograft survival with a clinically relevant CTLA4-Ig dosing regimen;Frontiers in Immunology;2022-12-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3